Investors

Who Invested in CellType?
CellType is backed by Y Combinator, according to public sources.
Simulates drug response in human biology using LLMs.
Angel Investor
Sahin Boydas
Angel Investor · 231 companies across 14 categories
Investors in CellType include Y Combinator. Of its investors, it is in the most other companies in Sahin’s portfolio.
Institutional Investors in CellType
Angel Investor: Sahin Boydas
Sahin Boydas
#1 most active angel investor in the U.S. in 2024 (Lenny's Newsletter)
- Companies
- 231
- Categories
- 14
- $1B+ Companies
- 46
- Biotech Companies
- 10
Why Angel Investors Matter for CellType
Angel investors like Sahin Boydas provide more than capital to companies like CellType. They bring early-stage validation, industry connections, and strategic guidance that help startups navigate from idea to product-market fit. CellType is part of a broader thesis on the Biotech market, where the public portfolio holds 10 companies in total. Each named investor links to its own public directory where one exists.
Angel investors typically invest at the earliest stages, when risk is highest but potential returns are greatest. CellType’s progress reflects the early conviction that angel investors placed in the company's vision and team.
This evidence-based directory lists investors in the sources below. It may not be complete.
CellType investors: questions and answers
Who invested in CellType?
CellType is backed by Y Combinator, according to public sources.
Which venture capital firms invested in CellType?
Venture capital firms named as investors in CellType: Y Combinator.
Which angel investors backed CellType?
Sahin Boydas is an angel investor in CellType, one of 231 companies in Sahin Boydas’s public angel portfolio.
Where does the list of CellType investors come from?
Every investor on this page is cited to a public source, such as PR Newswire / Senhwa Biosciences and Y Combinator. Only investors named in public reporting are listed, so the list may not be complete.
Browse more investors
Other AI companies with investors